Login to Your Account



Earnings Roundup


Tuesday, August 6, 2013
Immunogen Inc., of Waltham, Mass., reported a net loss, for the fiscal year ended June 30, 2013, of $72.8 million, or $0.87 per basic and diluted share, compared to a net loss of $73.3 million, or $0.95 per basic and diluted share, for the comparable period last year.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription